Gastro-intestinal Biopotential Recorder by Means of Surface ELEctrodes
Launched by CENTRAL HOSPITAL, NANCY, FRANCE · Jan 8, 2024
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the electrical signals from the intestines differ among three groups: healthy individuals, patients with Crohn's disease who do not have scarring (fibrosis), and those who do have fibrosis, as well as patients with functional gastrointestinal disorders (FGID). The main goal is to see if there are noticeable differences in these signals between the groups. Additionally, the study will look into whether these signals relate to established measures of Crohn's disease and FGID, such as MRI results and specific questionnaires.
To participate, individuals must be over 18 years old and have fasted for at least 12 hours. Healthy volunteers should have no history of gastrointestinal diseases, while Crohn's disease patients need to have recent MRI and blood test results. Participants will undergo two recordings with a special device placed on their abdomen: the first will be during fasting, and the second will happen after they eat a standard meal. It's important to note that certain people, like those with pacemakers, severe allergies, or certain medical conditions, cannot participate. Overall, this trial aims to improve understanding of gastrointestinal health and potentially enhance how these conditions are diagnosed and treated.
Gender
ALL
Eligibility criteria
- Inclusion Criteria for all participants:
- • Person age \> 18 years
- • Person has been fasting for at least 12 hours
- • Person who has received full information on the organization of the research and has not objected to the use of this data.
- • Person affiliated to or beneficiary of a social security plan
- • Person informed about study organization and having signed the informed consent
- Inclusion Criteria for healthy volunteers :
- • Person has no history of chronic gastro-intestinal disease
- • Person has no acute of gastro-intestinal disease
- Inclusion Criteria for Crohn's disease patients without fibrosis :
- • Person is already diagnosed with Crohn's disease
- * Person has underwent during the last 6 months :
- • An MRI showing no fibrosis
- • A blood test for C-reactive protein and fecal calprotectine
- • A questionnaire to asses the Harvey-Bradshaw Index
- Inclusion Criteria for Crohn's disease patients with fibrosis :
- • Person is already diagnosed with Crohn's disease
- * Person has underwent during the last 6 months :
- • An MRI showing fibrosis
- • A blood test for C-reactive protein and fecal calprotectine
- • A questionnaire to asses the Harvey-Bradshaw Index
- Inclusion Criteria for functional gastrointestinal disorders patients :
- • Person is already diagnosed with functional gastrointestinal disorders
- • Person has underwent an evaluation of the Rome IV criteria
- Exclusion Criteria for all participants:
- • Person having a pacemaker
- • Person suffering from a sensory disorder making insensitive to pain on the skin
- • Person suffering from a mental or motor disorders creating uncontroled movements
- • Person being allergic to one or more component of the device
- • Person being allergic to : soy, dairy food, peanuts, wheat, nuts
- • Person having an history of gastro-intestinal surgery
- • Person suffering from injury or erythema on the abdominal skin
- • Person having a contagious potential (bacterial, fungal or viral)
- • Person being in menstruation period
- • Person suffering from urinary incontinence
- • Minor (not emancipated)
- • Person of legal age (subject to a legal protection measure)
- • Adult unable to give consent
About Central Hospital, Nancy, France
Central Hospital, located in Nancy, France, is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes. As a prominent clinical trial sponsor, the hospital is committed to conducting innovative studies across various therapeutic areas, fostering collaboration among multidisciplinary teams of healthcare professionals and researchers. With a strong emphasis on ethical standards and patient safety, Central Hospital leverages its state-of-the-art facilities and expertise to contribute to the development of cutting-edge treatments and enhance the overall quality of care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vandœuvre Lès Nancy, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported